Current Medicinal Insights on Synthetic Small Molecules and NaturalOrigin Products as PD-1/PD-L1 Inhibitors
Shivanshu Pandey(Indo Soviet Friendship College of Pharmacy), Preeti Patel(Indo Soviet Friendship College of Pharmacy), Balak Das Kurmi(Indo Soviet Friendship College of Pharmacy)
Cited by 2
Related Papers
Solid lipid nanoparticles: a review on recent perspectives and patents
|Expert Opinion on Therapeutic Patents|2020|323
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Micro- and nanocarrier-mediated lung targeting
|Expert Opinion on Drug Delivery|2010|121
Transdermal Drug Delivery: Opportunities and Challenges for Controlled Delivery of Therapeutic Agents Using Nanocarriers
|Current Drug Metabolism|2017|107